Dora Buonfrate
Overview
Explore the profile of Dora Buonfrate including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
162
Citations
2704
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Francisco N, Gaviraghi A, Alladio F, Huits R, Carnielli B, Salvador E, et al.
Emerg Infect Dis
. 2025 Mar;
31(3):627-629.
PMID: 40023821
In a longitudinal study in a first-level hospital in Luanda, Angola, we found rifampin-resistant and multidrug-resistant tuberculosis (TB) in 38 (8%, 95% CI 5.7-10.8) of 474 patients with no previous...
2.
Buonfrate D, Ferrari T, Adegnika A, Stothard J, Gobbi F
Lancet
. 2025 Feb;
405(10479):658-670.
PMID: 39986748
Schistosomiasis is a neglected tropical disease caused by infection with blood flukes of the genus Schistosoma. Widely distributed in the Middle East, southeast Asia, Latin America, and (mostly) sub-Saharan Africa,...
3.
Tamarozzi F, Mazzi C, Antinori S, Arsuaga M, Becker S, Bocanegra C, et al.
Travel Med Infect Dis
. 2025 Feb;
64:102822.
PMID: 39983934
Background: The diagnostic and treatment approaches for schistosomiasis in individual patients, outside endemic areas, are not standardised. This study aimed to appraise the reference documents that the experts from the...
4.
Henriquez-Camacho C, Perez-Molina J, Buonfrate D, Rodari P, Gotuzzo E, Luengo B, et al.
Parasitology
. 2025 Jan;
1-7.
PMID: 39819639
The aim was to assess the efficacy of ivermectin moxidectin for treating infection. Ovid MEDLINE, Embase and Web of Science databases were searched for studies comparing ivermectin and moxidectin from...
5.
6.
Roose S, Prato M, Kazienga A, Peelaers I, Arens J, Leta G, et al.
Parasit Vectors
. 2024 Dec;
17(1):534.
PMID: 39716205
Background: Strongyloidiasis is a neglected tropical disease (NTD) caused by the soil-transmitted helminth Strongyloides stercoralis, recently included in the 2030 targets of the World Health Organization for the control of...
7.
Scarso S, Tamarozzi F, Mazzi C, Degani M, Rizzi E, Tais S, et al.
Parasit Vectors
. 2024 Dec;
17(1):535.
PMID: 39716196
Background: Strongyloidiasis is a chronic parasitic disease that results in relevant human morbidity, caused by the nematode Strongyloides stercoralis. This nematode has a unique and complex life-cycle. There is so...
8.
Review of the WHO guideline on preventive chemotherapy for public health control of strongyloidiasis
Lo N, Addiss D, Buonfrate D, Amor A, Anegagrie M, Bisoffi Z, et al.
Lancet Infect Dis
. 2024 Oct;
25(3):e146-e152.
PMID: 39481419
Strongyloidiasis is a soil-transmitted helminthiasis that is estimated to affect 300-600 million people across Asia, Africa, South and central America, and the Pacific. This neglected parasitic disease is most known...
9.
Pomari E, Orza P, Bernardi M, Fracchetti F, Campedelli I, De Marta P, et al.
Microorganisms
. 2024 Aug;
12(8).
PMID: 39203445
Differentiating between species is relevant in human medicine. toxins might be effective against , a nematode causing relevant human morbidity. Our first objective was to evaluate genomic and MALDI-TOF identification...
10.